logo

For the Inventor, By the Inventor

Cerritos, CA, United States of America

Richard K Hart

This inventor holds 4 USPTO granted patents. Top assignees: American Diagnostica, Inc., Mcgill University, The University of Toledo. Active years: 1978-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard K Hart. Retrieved from https://idiyas.com/inventor/richard-k-hart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 88(Granted Patents)


Location History:

  • Cerritos, CA (US) (1978 - 1979)
  • Greenwich, CT (US) (1997 - 2000)

Company Filing History:

goldMedal1 out of 7 
 
American Diagnostica, Inc.
 patents
silverMedal1 out of 570 
 
Mcgill University
 patents
bronzeMedal1 out of 369 
 
The University of Toledo
 patents
4. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1978-2000

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6077508 - Urokinase plasminogen activator receptor as a target for diagnosis of (2000-06-20),
2. 5679350 - Method of delivery of a medicament to a cancer cell using a pathway of (1997-10-21),
3. 4174850 - Fender flare clip apparatus (1979-11-20),
4. 4109957 - Quickly removable windshield curtain (1978-08-29),

Title: Richard K Hart: Innovator in Cancer Treatment

Introduction

Richard K Hart is a notable inventor based in Cerritos, CA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, Hart's work focuses on the diagnosis and treatment of cancer, particularly through the use of specific molecular targets.

Latest Patents

Hart's latest patents include groundbreaking inventions such as the use of urokinase plasminogen activator receptor (uPAR) as a target for diagnosis. This invention relates to the use of molecules that can specifically bind to uPAR as diagnostic reagents for detecting metastases in vivo. Another significant patent involves a method of delivering a medicament to cancer cells using activated plasminogen activator materials. This method ensures that the medicament is effectively transferred into the cancer cell, enhancing treatment efficacy.

Career Highlights

Throughout his career, Richard K Hart has worked with various institutions, including the University of Toledo. His innovative approaches have positioned him as a key figure in cancer research and treatment methodologies.

Collaborations

Hart has collaborated with notable individuals in his field, including Shafaat A Rabbani and Jerzy Jankun. These collaborations have further enriched his research and development efforts.

Conclusion

Richard K Hart's contributions to cancer treatment through his patents demonstrate his commitment to advancing medical science. His innovative methods and collaborative efforts continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…